Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORTIS: 3HP for TB Prevention in COR+ Individuals
NCT02735590Phase 3Unknown
- Sponsor
- University of Cape Town
- Start
- Sep 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of isoniazid, rifapentine in pulmonary tuberculosis (TB), sponsored by University of Cape Town. Status: unknown.
02
Drugs
isoniazidrifapentine
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT02735590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02735590.